about
Present and future in the treatment of diabetic kidney diseaseObservational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA studyAdjuvant Ciprofloxacin for Persistent BK Polyomavirus Infection in Kidney Transplant Recipients.Intraperitoneal fluid overestimates hydration status assessment by bioimpedance spectroscopy.Metformin-associated acute kidney injury and lactic acidosis.Mineral metabolism factors predict accelerated progression of common carotid intima-media thickness in chronic kidney disease: the NEFRONA study.Skin Autofluorescence and Subclinical Atherosclerosis in Mild to Moderate Chronic Kidney Disease: A Case-Control Study.Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD.Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study.Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project.Bloodstream infections in patients with kidney disease: risk factors for poor outcome and mortality.A Spanish multicentric study to evaluate the clinical activity of nephrology fellows during in-hospital on-call shifts.Factors predicting cardiovascular events in chronic kidney disease patients. Role of subclinical atheromatosis extent assessed by vascular ultrasound.Impact of the Limitations in Fluid Overload Assessment by Bioimpedance Spectroscopy.Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus.New perspectives on CKD-induced dyslipidemia.Albumin leakage in online hemodiafiltration, more convective transport, more losses?Beyond the traditional lipid parameters in chronic kidney disease.Protein-bound toxins: added value in their removal with high convective volumes.The effect of replacing aluminium hydroxide with calcium acetate/magnesium carbonate on serum phosphorus control in haemodialysis patientsIntraindividual interleukin-6 variations on the cardiovascular prognosis of patients with chronic renal diseaseAcute kidney failure in the context of a Tako-Tsubo syndromeInfective endocarditis on a percutaneous prosthetic aortic valve with associated glomerulopathy due to Granulicatella adjacensMonitoring of circulating antibodies in a renal transplantation population: preliminary resultsUtility of bioimpedance spectroscopy (BIS) in the management of refractory hypertension in patients with chronic kidney disease (CKD)[Metabolic syndrome is associated with cardiovascular events in haemodialysis]Hypercalcemia as a side effect of potassium binding agents
P50
Q26864133-516FC246-9197-4888-88E3-45477A1246B3Q30862443-75AEBD84-1C78-4CD2-85EB-0D73327D2006Q33668087-026B7C50-76FC-48EA-8E25-0CB04620CF92Q35106092-83D2443A-765D-4949-8A79-C1764CB9E4A5Q35116393-E57723DF-D915-40D6-A710-B0F4B36F2EF9Q36114992-11D74B49-BAE7-40CC-A159-63714475BE84Q36264876-D94BEDEB-9C45-4F1A-BFD0-9BD8EA934E40Q36543044-1306EB03-2687-4894-ABD5-3901990B8416Q39757983-64EAA1EB-B42F-4AA5-BBFA-0651DC4EDBEBQ39863731-97174FEC-0B97-4807-80E1-A35A4A6C485FQ40235771-C2C2DB00-F4F6-4A13-98F3-B65459A12ACAQ40846260-4D934DFF-2FF2-45E6-BD7C-051955DDA7AFQ42680128-560397B3-86C3-4F9A-B35F-44A406F9218DQ43229335-EE1DCECD-2ADD-4F87-AE5F-FBDC8F139D34Q44098648-2BA3D64E-B93D-402B-BDCB-4079B8A83A10Q47922360-B0494855-0E9C-4C70-802F-7A7C35DB20C8Q48256558-8B4C440F-2D02-43E6-AC19-8024617070DAQ50018040-EE1836BC-1BA1-4BBE-AEC0-5E723E34859FQ51535664-BE6A0C5B-CC08-47DF-9F53-A97BCEF9D9D1Q57217436-3FF5BFC8-BF7B-41F4-BCCB-276E682DD15AQ84495711-74B1281C-1343-4087-A708-9D2D8B5D9B1FQ84520831-23025551-43A5-4469-830A-F497EE404C17Q85416586-99400597-0A9E-4AF2-9B56-5944FF23AB50Q85417531-96A60129-FEA0-45A0-ACEF-E52BF4CF2291Q85758813-0C905E8C-9FB5-46BB-BFDE-2C796621C08AQ87165243-4F1F2A47-8F58-4372-BBF3-8FBBD9B2DD8EQ87381573-7C20806B-43E4-4228-A282-AC7AA6D602E4
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
David Arroyo
@ast
David Arroyo
@en
David Arroyo
@es
David Arroyo
@nl
type
label
David Arroyo
@ast
David Arroyo
@en
David Arroyo
@es
David Arroyo
@nl
prefLabel
David Arroyo
@ast
David Arroyo
@en
David Arroyo
@es
David Arroyo
@nl
P108
P106
P108
P1153
55358621700
P21
P31
P496
0000-0003-4652-0311